FutureTech /
Longevity
FutureTech and Longevity Biomedical Set Business Combination




Source for the buyer and target: Longevity Biomedical Holdings Corp.
For the buyer and target.
“FutureTech and Longevity have agreed to a business combination through a series of transactions, including the Mergers, subject to the terms and conditions of the Merger Agreement and the other transaction agreements.”
Published 12 Nov 2025
Open the sourceWhat happened
FutureTech and Longevity Biomedical, Inc. entered into a business combination agreement. The transaction includes Longevity merging with Merger Sub, with Longevity surviving as a wholly owned subsidiary of PubCo. [01]
The filing states that merger consideration is calculated as $100,000,000 less the value of certain converted stock options, divided by $10.00 per share, and payable in PubCo common stock. [01]
The source
Everything on this page comes from the source below, quoted word for word.
FutureTech and Longevity Biomedical Set Business Combination
This document is the source for the companies, stage, figure and people on this page.
Open the sourceTimeline
Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Get ProAlready a member? Sign in
Pro is open to everyone.
By email · Weekly